Endoron Medical

About Endoron Medical

Endoron Medical is a company focused on providing innovative solutions for patients with Abdominal Aortic Aneurysm (AAA) undergoing Endovascular Aneurysm Repair (EVAR). Their mission is to deliver long-lasting sealing and fixation solutions for endografts to ensure stability and prevent complications.

Products & Services

Aortoseal™:A fixation and sealing device for stent grafts during EVAR procedures. It uses a smart stapling mechanism to secure the stent graft to the aortic wall, mimicking surgical anastomosis. It is designed for complex aortic anatomies, offers fast deployment, and reduces complications.

Specialties

Endovascular Aneurysm Repair (EVAR) Abdominal Aortic Aneurysm (AAA) treatment Stent graft fixation and sealing technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 10000000 MR: - FA: 10 million FAN: 10000000	D: 2024-07-09 FD: 2024-07-09	2 investors

Series A Latest

2024-07-09

$10.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Ronit Harpaz

Co-founder & CEO

E

Eyal Teichman

Co-Founder & CTO

D

Dr. Ron Karmeli

Co-Founder & CMO

D

Dr. Jacques Seguin

Chairman of the Board

D

Dr. Avi Ludomirsky

Board member

C

Cécile Dupont

Partner, Sofinnova Partners MD Start Strategy

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

Endoron Medical Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised